Cargando…

Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists

Transient receptor potential ankyrin 1 (TRPA1) channel is an ion channel whose gating is controlled by agonists, such as allyl isothiocyanate (AITC), and temperature. Since TRPA1 is associated with various disease symptoms and chemotherapeutic side effects, it is a frequent target of drug developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Megumi, Yamamiya, Ryodai, Shimizu, Yuto, Yoshimura, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550780/
https://www.ncbi.nlm.nih.gov/pubmed/33117171
http://dx.doi.org/10.3389/fphar.2020.578955
_version_ 1783593039875276800
author Yoshida, Megumi
Yamamiya, Ryodai
Shimizu, Yuto
Yoshimura, Kenjiro
author_facet Yoshida, Megumi
Yamamiya, Ryodai
Shimizu, Yuto
Yoshimura, Kenjiro
author_sort Yoshida, Megumi
collection PubMed
description Transient receptor potential ankyrin 1 (TRPA1) channel is an ion channel whose gating is controlled by agonists, such as allyl isothiocyanate (AITC), and temperature. Since TRPA1 is associated with various disease symptoms and chemotherapeutic side effects, it is a frequent target of drug development. To facilitate the screening of TRPA1 agonists and antagonists, this study aimed to develop a simple bioassay for TRPA1 activity. To this end, transgenic Chlamydomonas reinhardtii expressing human TRPA1 was constructed. The transformants exhibited positive phototaxis at high temperatures (≥20°C) but negative phototaxis at low temperatures (≤15°C); wild-type cells showed positive phototaxis at all temperatures examined. In the transgenic cells, negative phototaxis was inhibited by TRPA1 antagonists, such as HC030031, A-967079, and AP18, at low temperatures. Negative phototaxis was induced by TRPA1 agonists, such as icilin and AITC, at high temperatures. The effects of these agonists were blocked by TRPA1 antagonists. In wild-type cells, none of these substances had any effects on phototaxis. These results indicate that the action of TRPA1 agonists and antagonists can be readily assessed using the behavior of C. reinhardtii expressing human TRPA1 as an assessment tool.
format Online
Article
Text
id pubmed-7550780
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75507802020-10-27 Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists Yoshida, Megumi Yamamiya, Ryodai Shimizu, Yuto Yoshimura, Kenjiro Front Pharmacol Pharmacology Transient receptor potential ankyrin 1 (TRPA1) channel is an ion channel whose gating is controlled by agonists, such as allyl isothiocyanate (AITC), and temperature. Since TRPA1 is associated with various disease symptoms and chemotherapeutic side effects, it is a frequent target of drug development. To facilitate the screening of TRPA1 agonists and antagonists, this study aimed to develop a simple bioassay for TRPA1 activity. To this end, transgenic Chlamydomonas reinhardtii expressing human TRPA1 was constructed. The transformants exhibited positive phototaxis at high temperatures (≥20°C) but negative phototaxis at low temperatures (≤15°C); wild-type cells showed positive phototaxis at all temperatures examined. In the transgenic cells, negative phototaxis was inhibited by TRPA1 antagonists, such as HC030031, A-967079, and AP18, at low temperatures. Negative phototaxis was induced by TRPA1 agonists, such as icilin and AITC, at high temperatures. The effects of these agonists were blocked by TRPA1 antagonists. In wild-type cells, none of these substances had any effects on phototaxis. These results indicate that the action of TRPA1 agonists and antagonists can be readily assessed using the behavior of C. reinhardtii expressing human TRPA1 as an assessment tool. Frontiers Media S.A. 2020-09-29 /pmc/articles/PMC7550780/ /pubmed/33117171 http://dx.doi.org/10.3389/fphar.2020.578955 Text en Copyright © 2020 Yoshida, Yamamiya, Shimizu and Yoshimura http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yoshida, Megumi
Yamamiya, Ryodai
Shimizu, Yuto
Yoshimura, Kenjiro
Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title_full Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title_fullStr Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title_full_unstemmed Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title_short Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
title_sort transgenic chlamydomonas expressing human transient receptor potential ankyrin 1 (trpa1) channels to assess the effect of agonists and antagonists
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550780/
https://www.ncbi.nlm.nih.gov/pubmed/33117171
http://dx.doi.org/10.3389/fphar.2020.578955
work_keys_str_mv AT yoshidamegumi transgenicchlamydomonasexpressinghumantransientreceptorpotentialankyrin1trpa1channelstoassesstheeffectofagonistsandantagonists
AT yamamiyaryodai transgenicchlamydomonasexpressinghumantransientreceptorpotentialankyrin1trpa1channelstoassesstheeffectofagonistsandantagonists
AT shimizuyuto transgenicchlamydomonasexpressinghumantransientreceptorpotentialankyrin1trpa1channelstoassesstheeffectofagonistsandantagonists
AT yoshimurakenjiro transgenicchlamydomonasexpressinghumantransientreceptorpotentialankyrin1trpa1channelstoassesstheeffectofagonistsandantagonists